Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.
Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...
With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.210084033613 | 4.76 | 4.95 | 4.44 | 103382 | 4.58660818 | CS |
4 | -0.47 | -9.00383141762 | 5.22 | 5.4799 | 4.44 | 92876 | 4.7835518 | CS |
12 | -1.51 | -24.1214057508 | 6.26 | 11.8 | 4.44 | 180558 | 6.78049595 | CS |
26 | -2.46 | -34.1192787795 | 7.21 | 11.8 | 4.44 | 129584 | 6.72044732 | CS |
52 | -3.76 | -44.1833137485 | 8.51 | 12.1 | 4.44 | 112203 | 7.19228803 | CS |
156 | 0.8 | 20.253164557 | 3.95 | 20.92 | 3.08 | 188863 | 7.84114017 | CS |
260 | 0.8 | 20.253164557 | 3.95 | 20.92 | 3.08 | 188863 | 7.84114017 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約